×
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

Belagavi Ayush medicine unit to shift to Bengaluru

Last Updated : 16 August 2018, 12:44 IST
Last Updated : 16 August 2018, 12:44 IST

Follow Us :

Comments

Belagavi South MLA Abhay Patil condemned the decision of the state government to shift the Ayush medicine manufacturing unit from the Vaccine Depot premises at Tilakwadi in Belagavi; to Bengaluru.

He remarked that the shift was an indication that the state government lacked commitment in developing north Karnataka districts.

It maybe recalled that, recently the state government had announced the shifting of the divisional office of the Karnataka State Highway Improvement Project (KSHIP) to Hassan. This move had drawn flak from northern district leaders and mutt seers.

Patil told reporters here on Thursday, that recently Chief Minister H D Kumaraswamy, had assured to shift few government offices to Belagavi and make it the second capital of the state.

"However, now the government is doing just the opposite by shifting the Ayush unit to the CM's constituency in the south," Patil pointed out.

He indicated that there would be trouble during the winter session of the Legislative Assembly in Belagavi later in the year, if the government keeps at shifting offices down south.

Funds for Belagavi city development had not been released since JD(S)-Congress coalition government came to power. Over Rs 200 crore was required for making bad roads motorable. A Belagavi leaders' delegation would meet the CM on Monday or Tuesday seeking immediate release of funds for basic city infrastructure.

The delegation would also meet Deputy Chief Minister and Home Minister G Parameshwara and demand an inquiry into the failure of the city police in checking the narcotics menace in the city. Certain hotels and bars in Udyambag area were open all night and indulging in illegal activities, Patil alleged.

ADVERTISEMENT
Published 16 August 2018, 06:58 IST

Deccan Herald is on WhatsApp Channels| Join now for Breaking News & Editor's Picks

Follow us on :

Follow Us

ADVERTISEMENT
ADVERTISEMENT